会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHODS AND KITS FOR ASSAYS OF RAPID SCREENING OF DIABETES
    • 用于糖尿病快速筛选的方法和试剂盒
    • WO2004046726A2
    • 2004-06-03
    • PCT/EP2003/012958
    • 2003-11-19
    • NOVARTIS AGNOVARTIS PHARMA GMBHMORRIS, Carol, AnnCARNEY, Fiona, PatriciaLANE, Jennifer, Dawn
    • MORRIS, Carol, AnnCARNEY, Fiona, PatriciaLANE, Jennifer, Dawn
    • G01N33/66
    • G01N33/6893G01N33/66G01N2800/042
    • The invention provides an in vivo screening assay and an in vitro screening assay for rapid screening of diabetes. A method of the invention includes determining a first glucose concentration in an ocular fluid of a patient; administering orally a load of carbohydrate to the patient; determining a second glucose concentration in an ocular fluid of the patient at a period of time of less than 50 minutes after orally administering of the load of carbohydrate; comparing the second glucose concentration with the first glucose concentration to determine if the patient is likely to be a diabetic. The method of the invention is performed by using a kit of the invention. The kit comprises: (1) a glucose-sensing ophthalmic device and instructions for using the glucose-sensing ophthalmic device to screen for diabetes; or (2) two or more tear-collecting devices, and a testing agent composition which specifically reacts with glucose to form a detectable signal. The glucose-sensing ophthalmic device comprises a testing agent composition which specifically and reversibly interacts with glucose to form a detectable optical signal which changes in a concentration-dependent manner.
    • 本发明提供体内筛选测定和用于快速筛选糖尿病的体外筛选测定。 本发明的方法包括确定患者眼部流体中的第一葡萄糖浓度; 向患者口服负荷的碳水化合物; 在口服施用碳水化合物之后,在小于50分钟的时间内测定患者眼液中的第二葡萄糖浓度; 将第二葡萄糖浓度与第一葡萄糖浓度进行比较以确定患者是否可能是糖尿病。 本发明的方法通过使用本发明的试剂盒进行。 试剂盒包括:(1)葡萄糖感测眼科装置和使用葡萄糖感测眼科装置筛查糖尿病的说明书; 或(2)两种或更多种泪液收集装置,以及与葡萄糖特异性反应以形成可检测信号的检测剂组合物。 葡萄糖感测眼科装置包括与葡萄糖特异性和可逆地相互作用以形成以浓度依赖性方式变化的可检测光学信号的测试剂组合物。
    • 2. 发明申请
    • CONTACT LENS PACKAGING SOLUTIONS
    • 联系人镜头包装解决方案
    • WO2009032122A1
    • 2009-03-12
    • PCT/US2008/010146
    • 2008-08-27
    • NOVARTIS AGMINICK, Kasey, JonCARNEY, Fiona, PatriciaSENTELL, Karen, BelindaMINNO, George, Edward
    • MINICK, Kasey, JonCARNEY, Fiona, PatriciaSENTELL, Karen, BelindaMINNO, George, Edward
    • G02B1/04A61L12/08
    • B65B25/008A61L12/04G02B1/043
    • An ophthalmic product, comprising a sealed and sterilized package which include a packaging solution and a soft hydrogel contact lens immersed in the packaging solution, wherein the packaging solution includes: a homopolymer or copolymer of vinylpyrrolidone, wherein the homopolymer or copolymer of vinylpyrrolidone is present in an amount sufficient to provide the packaging solution a viscosity of up to about 5.0 centipoises at 25°C; glycerin or a polyethylene glycol having an average molecular weight of about 600 or less; an α-oxo-multi-acid or salt thereof in an amount sufficient to have a reduced susceptibility to oxidation degradation of the polyethylene glycol in the packaging solution; and one or more buffering agents in an amount sufficient to provide the solution a pH of from about 6.0 to 8.0, wherein the packaging solution has an osmolality of from about 200 to about 450 mOsm/kg. The application further provides a process for making a soft contact lens capable of easing wearer's initial discomfort.
    • 一种眼科产品,包括密封和灭菌的包装,其包括浸没在包装溶液中的包装溶液和软水凝胶隐形眼镜,其中所述包装溶液包括:乙烯基吡咯烷酮的均聚物或共聚物,其中乙烯基吡咯烷酮的均聚物或共聚物存在于 足以使包装溶液在25℃下的粘度高达约5.0厘泊; 甘油或平均分子量为约600以下的聚乙二醇; 一种α-氧代多酸或其盐,其量足以使包装溶液中聚乙二醇氧化降解的敏感性降低; 和一种或多种缓冲剂,其量足以提供约6.0至8.0的pH,其中所述包装溶液的重量摩尔渗透压浓度为约200至约450mOsm / kg。 该应用还提供了一种制造能够减轻佩戴者初始不适的柔软隐形眼镜的方法。
    • 8. 发明申请
    • METHODS AND KITS FOR ASSAYS OF RAPID SCREENING OF DIABETES
    • 用于糖尿病快速筛选的方法和试剂盒
    • WO2004046726A3
    • 2005-01-06
    • PCT/EP0312958
    • 2003-11-19
    • NOVARTIS AGNOVARTIS PHARMA GMBHMORRIS CAROL ANNCARNEY FIONA PATRICIALANE JENNIFER DAWN
    • MORRIS CAROL ANNCARNEY FIONA PATRICIALANE JENNIFER DAWN
    • A61B5/00C12Q1/54G01N33/66G01N33/68A61B10/00G01N33/52G01N33/542
    • G01N33/6893G01N33/66G01N2800/042
    • The invention provides an in vivo screening assay and an in vitro screening assay for rapid screening of diabetes. A method of the invention includes determining a first glucose concentration in an ocular fluid of a patient; administering orally a load of carbohydrate to the patient; determining a second glucose concentration in an ocular fluid of the patient at a period of time of less than 50 minutes after orally administering of the load of carbohydrate; comparing the second glucose concentration with the first glucose concentration to determine if the patient is likely to be a diabetic. The method of the invention is performed by using a kit of the invention. The kit comprises: (1) a glucose-sensing ophthalmic device and instructions for using the glucose-sensing ophthalmic device to screen for diabetes; or (2) two or more tear-collecting devices, and a testing agent composition which specifically reacts with glucose to form a detectable signal. The glucose-sensing ophthalmic device comprises a testing agent composition which specifically and reversibly interacts with glucose to form a detectable optical signal which changes in a concentration-dependent manner.
    • 本发明提供体内筛选测定和用于快速筛选糖尿病的体外筛选测定。 本发明的方法包括确定患者眼部流体中的第一葡萄糖浓度; 向患者口服负荷的碳水化合物; 在口服施用碳水化合物之后,在小于50分钟的时间内测定患者眼液中的第二葡萄糖浓度; 将第二葡萄糖浓度与第一葡萄糖浓度进行比较以确定患者是否可能是糖尿病。 本发明的方法通过使用本发明的试剂盒进行。 试剂盒包括:(1)葡萄糖感测眼科装置和使用葡萄糖感测眼科装置筛查糖尿病的说明书; 或(2)两种或更多种泪液收集装置,以及与葡萄糖特异性反应以形成可检测信号的检测剂组合物。 葡萄糖感测眼科装置包括与葡萄糖特异性和可逆地相互作用以形成以浓度依赖性方式变化的可检测光学信号的测试剂组合物。